rs72671125
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001365999.1(SZT2):c.6888C>T(p.Cys2296Cys) variant causes a synonymous change. The variant allele was found at a frequency of 0.0233 in 1,613,892 control chromosomes in the GnomAD database, including 507 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001365999.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0193 AC: 2940AN: 152212Hom.: 39 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0203 AC: 5086AN: 250364 AF XY: 0.0206 show subpopulations
GnomAD4 exome AF: 0.0237 AC: 34598AN: 1461562Hom.: 468 Cov.: 33 AF XY: 0.0234 AC XY: 16994AN XY: 727078 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0193 AC: 2939AN: 152330Hom.: 39 Cov.: 33 AF XY: 0.0196 AC XY: 1461AN XY: 74490 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4
- -
- -
- -
- -
Developmental and epileptic encephalopathy, 18 Benign:1
- -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at